ArrowMark Colorado Holdings’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,289
Closed -$3.89M 332
2019
Q2
$3.89M Sell
7,289
-6,333
-46% -$3.38M 0.04% 215
2019
Q1
$6.87M Sell
13,622
-2,867
-17% -$1.44M 0.06% 192
2018
Q4
$8.13M Buy
16,489
+3,334
+25% +$1.64M 0.09% 187
2018
Q3
$12M Buy
13,155
+22
+0.2% +$20.1K 0.1% 174
2018
Q2
$9.62M Sell
13,133
-52
-0.4% -$38.1K 0.09% 184
2018
Q1
$21M Sell
13,185
-15,533
-54% -$24.8M 0.21% 110
2017
Q4
$25.7M Sell
28,718
-1,882
-6% -$1.69M 0.26% 99
2017
Q3
$11M Hold
30,600
0.13% 147
2017
Q2
$8.97M Buy
30,600
+4,000
+15% +$1.17M 0.11% 156
2017
Q1
$9.36M Sell
26,600
-1,873
-7% -$659K 0.13% 138
2016
Q4
$5.24M Hold
28,473
0.08% 180
2016
Q3
$7.34M Sell
28,473
-4,187
-13% -$1.08M 0.13% 143
2016
Q2
$6.97M Hold
32,660
0.14% 137
2016
Q1
$6.74M Buy
32,660
+6,133
+23% +$1.26M 0.15% 127
2015
Q4
$6.71M Hold
26,527
0.18% 126
2015
Q3
$4.36M Buy
26,527
+2,200
+9% +$362K 0.12% 153
2015
Q2
$4.57M Hold
24,327
0.11% 156
2015
Q1
$4.01M Buy
24,327
+23,174
+2,010% +$3.82M 0.1% 150
2014
Q4
$268K Hold
1,153
0.01% 242
2014
Q3
$209K Hold
1,153
0.01% 278
2014
Q2
$222K Hold
1,153
0.01% 273
2014
Q1
$210K Hold
1,153
0.01% 257
2013
Q4
$196K Sell
1,153
-1,460
-56% -$248K 0.01% 254
2013
Q3
$409K Buy
2,613
+1,460
+127% +$229K 0.01% 237
2013
Q2
$200K Buy
+1,153
New +$200K 0.05% 96